|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 809.30 BDT | -0.46% |
|
+2.25% | +14.31% |
| Market Cap | 181.56Cr 1.47Cr 1.28Cr 1.19Cr 1.09Cr 2.06Cr 140.1Cr 2.09Cr 14Cr 5.49Cr 70Cr 5.51Cr 5.39Cr 233.88Cr | P/E 2024 |
189x | P/E 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 232.19Cr 1.88Cr 1.63Cr 1.52Cr 1.39Cr 2.63Cr 179.17Cr 2.67Cr 18Cr 7.03Cr 89Cr 7.05Cr 6.89Cr 299.1Cr | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | -0.46% | ||
| 1 week | +2.25% | ||
| Current month | -0.46% | ||
| 1 month | +7.33% | ||
| 3 months | +7.51% | ||
| 6 months | +7.02% | ||
| Current year | +14.31% |
| 1 week | 803 |  | 830 |
| 1 month | 751.1 | | 847 |
| Current year | 689 | | 847 |
| 1 year | 681 | | 895 |
| 3 years | 511 | | 1,302.3 |
| 5 years | 375.3 | | 1,302.3 |
| 10 years | 330 | | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.46% | +2.25% | -2.13% | +51.58% | 1.57Cr | |
| -1.36% | -0.52% | +19.61% | +72.09% | 5TCr | |
| +3.60% | +1.55% | +56.17% | +118.63% | 3.66TCr | |
| +0.08% | +4.61% | -2.69% | +26.47% | 1.25TCr | |
| -0.51% | +1.16% | +16.91% | +75.16% | 1.18TCr | |
| +2.41% | -0.76% | +30.73% | +130.67% | 903.81Cr | |
| -1.95% | -4.18% | +41.45% | -11.86% | 702.99Cr | |
| +0.76% | +1.19% | +14.56% | +33.03% | 679.37Cr | |
| -0.17% | +1.55% | +7.48% | +181.51% | 660.39Cr | |
| +0.39% | +3.39% | -35.25% | +8.97% | 549.26Cr | |
| Average | +0.27% | +0.96% | +14.68% | +68.62% | 1.46TCr | |
| Weighted average by Cap. | +0.50% | +1.27% | +25.55% | +80.45% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 22Cr 17.73L 15.41L 14.34L 13.17L 24.87L 17Cr 25.25L 1.69Cr 66.36L 8.42Cr 66.58L 65.11L 28Cr | 23Cr 18.64L 16.2L 15.08L 13.84L 26.14L 18Cr 26.55L 1.78Cr 69.76L 8.86Cr 69.99L 68.45L 30Cr |
| Net income | 96.83L 78.28T 68.05T 63.34T 58.15T 1L 74.72L 1L 7L 3L 37.2L 3L 3L 1.25Cr | 53.09L 42.92T 37.31T 34.73T 31.88T 60.21T 40.97L 61.14T 4L 2L 20.4L 2L 2L 68.39L |
| Net Debt | 44Cr 35.94L 31.25L 29.08L 26.7L 50.42L 34Cr 51.21L 3.43Cr 1.35Cr 17Cr 1.35Cr 1.32Cr 57Cr | 51Cr 40.93L 35.58L 33.11L 30.4L 57.41L 39Cr 58.3L 3.9Cr 1.53Cr 19Cr 1.54Cr 1.5Cr 65Cr |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | BDT 814.70 | +0.67% | 332 |
| 02/26/02 | BDT 809.30 | -0.46% | 1,427 |
| 30/26/30 | BDT 813.00 | -0.59% | 457 |
| 29/26/29 | BDT 817.80 | -1.03% | 810 |
| 28/26/28 | BDT 826.30 | +2.99% | 1,999 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Select your edition
All financial news and data tailored to specific country editions
